İ Doğan,
N Paksoy, N Ak, S Vatansever… - European Journal of …, 2023 - ncbi.nlm.nih.gov
Objective: The aim was to assess the prognostic variables in human epidermal growth factor
receptor 2 (HER2)-positive metastatic breast cancer patients receiving lapatinib plus …